# Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma

> **NCT01050491** · PHASE2 · TERMINATED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 17 (actual)

## Conditions studied

- Effect of Sitaxsentan on Airway Remodeling in Severe Asthma

## Interventions

- **DRUG:** sitaxentan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01050491
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** sitaxentan is not commercialized anymore
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050491, "Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01050491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*